- Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man2007 | Publication without faculty affiliation
- Anthracycline resistance mediated by reductive metabolism in cancer cells: The role of aldo-keto reductase 1C32014 | Faculty of Pharmacy in Hradec Králové
- Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man2007 | Faculty of Pharmacy in Hradec Králové
- Buparlisib is a novel inhibitor of daunorubicin reduction mediated by aldo-keto reductase 1C32019 | Faculty of Pharmacy in Hradec Králové
- Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile2018 | Faculty of Pharmacy in Hradec Králové
- Diet flavonoids inhibit specific aldo-keto reductase AKR1C3Publication without faculty affiliation
- The Role of Cytochromes P450 and Aldo-Keto Reductases in Prognosis of Breast Carcinoma Patients2014 | First Faculty of Medicine, Second Faculty of Medicine
- Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism2021 | Faculty of Pharmacy in Hradec Králové
- Contribution of aldo-keto reductases to the metabolism of the novel anticancer drug oracin in man2005 | Faculty of Pharmacy in Hradec Králové
- Contribution of Aldo-Keto Reductases to the Metabolism of the Novel Anticancer Drug Oracin in ManPublication without faculty affiliation
- Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C32008 | Central Library of Charles University
- Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C32008 | Faculty of Pharmacy in Hradec Králové
- Contribution of carbonyl reductase and aldo-keto reductase AKR1C2 to formation of C13-alcoholic metabolites of daunorubicinPublication without faculty affiliation
- AKR1C3 Inhibitory Potency of Naturally-occurring Amaryllidaceae Alkaloids of Different Structural Types2017 | Faculty of Pharmacy in Hradec Králové
- Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment2018 | Faculty of Pharmacy in Hradec Králové
- Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters2022 | Faculty of Pharmacy in Hradec Králové
- Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-292011 | Faculty of Pharmacy in Hradec Králové
- Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux2022 | Faculty of Pharmacy in Hradec Králové
- The role of aryl hydrocarbon receptor in regulation of enzymes involved in metabolic activation of polycyclic aromatic hydrocarbons in a model of rat liver progenitor cells2009 | Central Library of Charles University
- AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids2009 | Central Library of Charles University
- Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance2016 | Faculty of Pharmacy in Hradec Králové
- Carbonyl reduction pathways in drug metabolism2014 | Faculty of Pharmacy in Hradec Králové
- Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases2016 | Faculty of Pharmacy in Hradec Králové
- Regulation of human carbonyl reductase 3 (CBR3; SDR21C2) expression by Nrf2 in cultured cancer cells2010 | Central Library of Charles University
- Control of Steroid 21-oic Acid Synthesis by Peroxisome Proliferator-activated Receptor alpha and Role of the Hypothalamic-Pituitary-Adrenal Axis2010 | First Faculty of Medicine
- AKR1C3 as a potential target for the inhibitory effect of dietary flavonoidsPublication without faculty affiliation
- Bruton's Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib Counteract Anthracycline Resistance in Cancer Cells Expressing AKR1C32020 | Faculty of Pharmacy in Hradec Králové
- Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib2021 | Faculty of Pharmacy in Hradec Králové
- Age-Related Changes in Hepatic Activity and Expression of Detoxification Enzymes in Male Rats2013 | Faculty of Pharmacy in Hradec Králové
- Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C32020 | Faculty of Pharmacy in Hradec Králové